Morales GF, Montalvo GS

Idioma: Español
Referencias bibliográficas: 23
Paginas: 1-7
Archivo PDF: 415.71 Kb.

RESUMEN

Durante el abordaje de los pacientes con una patología predominantemente gastrointestinal es relevante considerar todas las porciones del tracto digestivo, siendo quizás la de mayor complejidad para valoración de su lumen el intestino delgado. Considerando además que los tumores de intestino delgado representan 30% de todas las neoplasias del tracto gastrointestinal, siendo malignas la mayoría se vuelve importante considerarlos dentro de diferencial en los pacientes principalmente con banderas rojas como síntomas constitucionales, principalmente perdida de peso no intencionada.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Maria P, Antoni C. Capítulo 30: Tumores del intestino delgado en Montoro M (compilador) et al. Gastroenterologia y hepatologia: Problemas comunes en la practica clinica. Madrid, Jarpyo Editores; 2012. p.435-442 ISBN: 978-84-92982-31-9.

2. Anita S. A practical approach to small lymphoid cell infiltrates in the lower gastrointestinal tract. Diagn Histopathol 2014; 137-143

3. Michael W, Keith D, et al. Greenfield’s surgery: scientific principles and practice 2011;50: 790-792.

4. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999;116: 1464–1486.

5. Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, et al. Brief report: alleviation of systemic manifestations of Castleman’s disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994; 330:602-5.

6. Shirley C, Carol E. Gastrointest Endoscopy Clin N Am: Small bowel tumors. 2009;19: 461-479.

7. Dave-Verma H, Moore S, Singh A, et al. Computed tomographic enterography and enteroclysis: pearls and pitfalls. Curr Probl Diagn Radiol 2008; 37(6):279–87.

8. Triester S, Leighton J, Leontiadis G, et al. A metaanalysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding. Am J Gastroenterol 2005; 100(11):2407–18.

9. Cobrin GM, Pittman RH, Lewis BS. Increased diagnostic yield of small bowell tumors with capsule endoscopy. Cancer 2006; 107:22-7.

10. Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 2005; 37:960-5.

11. Ottensmeier CH, Stevenson FK. Isotype switch variants reveal clonally related subpopulations in diffuse large B-cell lymphoma. Blood 2000; 96:2550.

12. Slack GW, Steidl C, Sehn LH, Gascoyne RD. CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia. Br J Haematol 2014; 167:608.

13. Stein H, Lennert K, Feller AC, Mason DY. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res 1984; 42:67.

14. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 2002; 99:815.

15. Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin’s lymphoma. Blood 1997; 90:244.

16. Colomo L, López-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003; 101:78.

17. Skinnider BF, Horsman DE, Dupuis B, Gascoyne RD. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 1999; 30:803.

18. De Leval L, Ferry JA, Falini B, et al. Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells? Am J Surg Pathol 2001; 25: 1277.

19. Rawls R, Vega K, Trotman B. Small bowel lymphoma. Curr Treat Options Gastroenterol 2003; 6(1):27–34.

20. Keung YK, Higgs V, Albertson DA, et al. Mucosaassociated lymhpoid tissue (MALT) lymphoma of the jejunum and Helicobacter pylori – chance association. Leuk Lymphoma 2003; 44(8):1413–6.

21. Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment and survival over the last 20 years. Ann Surg 2099; 249:63-71.

22. Cheung MC,Housri N, Ogilvie MP, el al. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. J surg Oncol 2009; 100:59-64.

23. Gollub MJ. Imaging of gastrointestinal lymphoma. Radiol Clin North Am 2008; 46:287-312.